Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Cinctive Capital Management LP

Key Points

• Cinctive Capital Management LP reduced its stake in Sabra Healthcare REIT by 53.9%, selling 94,037 shares, resulting in ownership of 80,504 shares valued at approximately $1.4 million.
• Sabra Healthcare REIT reported a quarterly earnings per share (EPS) of $0.38, surpassing estimates, with revenue of $189.15 million, reflecting a 7.4% increase compared to the previous year.
• The company announced a $0.30 quarterly dividend, leading to a dividend yield of 6.3% and a payout ratio of 157.89%.

Cinctive Capital Management LP decreased its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 53.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 80,504 shares of the real estate investment trust's stock after selling 94,037 shares during the quarter. Cinctive Capital Management LP's holdings in Sabra Healthcare REIT were worth $1,406,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Alliancebernstein L.P. raised its position in shares of Sabra Healthcare REIT by 5.7% during the 1st quarter. Alliancebernstein L.P. now owns 1,439,164 shares of the real estate investment trust's stock worth $25,142,000 after purchasing an additional 78,090 shares during the period. AQR Capital Management LLC lifted its stake in Sabra Healthcare REIT by 12.1% in the first quarter. AQR Capital Management LLC now owns 1,370,813 shares of the real estate investment trust's stock valued at $23,948,000 after buying an additional 147,955 shares during the last quarter. Advisors Asset Management Inc. boosted its holdings in shares of Sabra Healthcare REIT by 10.6% during the first quarter. Advisors Asset Management Inc. now owns 176,877 shares of the real estate investment trust's stock valued at $3,090,000 after acquiring an additional 16,886 shares during the period. Amundi grew its position in shares of Sabra Healthcare REIT by 4.7% during the first quarter. Amundi now owns 143,389 shares of the real estate investment trust's stock worth $2,531,000 after acquiring an additional 6,457 shares during the last quarter. Finally, EP Wealth Advisors LLC increased its holdings in shares of Sabra Healthcare REIT by 26.3% in the 1st quarter. EP Wealth Advisors LLC now owns 15,632 shares of the real estate investment trust's stock worth $273,000 after acquiring an additional 3,251 shares during the period. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Truist Financial boosted their target price on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a research note on Tuesday, September 2nd. JMP Securities boosted their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. BMO Capital Markets increased their price objective on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a report on Monday, August 25th. Scotiabank raised their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. Finally, Wells Fargo & Company lifted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $20.71.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ SBRA traded down $0.11 during mid-day trading on Tuesday, reaching $19.08. 1,507,353 shares of the company traded hands, compared to its average volume of 2,443,630. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The firm has a market cap of $4.58 billion, a PE ratio of 25.11, a price-to-earnings-growth ratio of 1.52 and a beta of 0.88. The stock has a fifty day simple moving average of $18.64 and a 200-day simple moving average of $17.91.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. The firm had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio (DPR) is currently 157.89%.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.